Immediate Impact

1 by Nobel laureates 2 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
2024 Standout
2 intermediate papers

Works of Rich Erickson being referenced

Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury
2018
Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease
2018

Author Peers

Author Last Decade Papers Cites
Rich Erickson 130 68 57 103 69 18 313
Michele Vigolo 91 33 42 135 54 17 315
Masakatsu Imamura 144 31 28 62 122 15 357
Christine Kowalczyk‐Quintas 75 40 33 186 21 14 323
A Hiraoka 120 22 18 118 34 19 323
S. John 153 57 25 48 49 15 341
Oppenheim Jj 152 20 42 49 68 18 326
Amar Bhatnagar 72 37 14 163 87 23 349
G. De Panfilis 135 17 20 48 41 19 304
H. Würz 69 29 34 148 67 24 347
George L. Manderino 74 14 57 148 92 24 362

All Works

Loading papers...

Rankless by CCL
2026